InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,609.20
(
-0.02%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
81.88
(
-1.19%
)
Bitcoin
62,194.67
(
-0.22%
)
Post# of 31637
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BottomBounce

Send PM Follow Ignore
Followers 898
Posts 148973
Boards Moderated 0
Alias Born 08/13/2010

BottomBounce

Re: TRAPPER JIM post# 31607

Thursday, 09/16/2021 8:52:08 AM

Thursday, September 16, 2021 8:52:08 AM

Post# of 31637
$IBIO The company also highlighted that it has entered into a research services agreement with FairJourney Biologics to gain access to novel display technologies and proprietary antibody libraries.
FairJourney is a biologics CRO, providing integrated services across antibody discovery, engineering and production to global biopharma.
"Our experience in antibody discovery for use in oncology has grown in recent years, with a number of undisclosed collaborations rapidly moving towards the clinic," António Parada, CEO at FairJourney said. https://seekingalpha.com/news/3713810-ibio-establishes-oncology-drug-discovery-pipeline-three-new-antibody-programs

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up